These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29724029)

  • 41. Salidroside improves high-fat diet-induced non-alcoholic steatohepatitis by regulating the gut microbiota-bile acid-farnesoid X receptor axis.
    Li H; Xi Y; Xin X; Tian H; Hu Y
    Biomed Pharmacother; 2020 Apr; 124():109915. PubMed ID: 31986416
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hepatocyte-Specific Disruption of CD36 Attenuates Fatty Liver and Improves Insulin Sensitivity in HFD-Fed Mice.
    Wilson CG; Tran JL; Erion DM; Vera NB; Febbraio M; Weiss EJ
    Endocrinology; 2016 Feb; 157(2):570-85. PubMed ID: 26650570
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The effect of cannabinoid receptor 1 blockade on adipokine and proinflammatory cytokine concentration in adipose and hepatic tissue in mice with nonalcoholic fatty liver disease.
    Jorgačević B; Vučević D; Vesković M; Mladenović D; Vukićević D; Vukićević RJ; Todorović V; Radosavljević T
    Can J Physiol Pharmacol; 2019 Feb; 97(2):120-129. PubMed ID: 30673308
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adiponectin deficiency rescues high-fat diet-induced hepatic injury, apoptosis and autophagy loss despite persistent steatosis.
    Guo R; Nair S; Zhang Y; Ren J
    Int J Obes (Lond); 2017 Sep; 41(9):1403-1412. PubMed ID: 28559541
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease.
    Yamada H; Ohashi K; Suzuki K; Munetsuna E; Ando Y; Yamazaki M; Ishikawa H; Ichino N; Teradaira R; Hashimoto S
    Clin Chim Acta; 2015 Jun; 446():267-71. PubMed ID: 25958847
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The effect of fibroblast growth factor 15 deficiency on the development of high fat diet induced non-alcoholic steatohepatitis.
    Schumacher JD; Kong B; Pan Y; Zhan L; Sun R; Aa J; Rizzolo D; Richardson JR; Chen A; Goedken M; Aleksunes LM; Laskin DL; Guo GL
    Toxicol Appl Pharmacol; 2017 Sep; 330():1-8. PubMed ID: 28673684
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The pan-caspase inhibitor Emricasan (IDN-6556) decreases liver injury and fibrosis in a murine model of non-alcoholic steatohepatitis.
    Barreyro FJ; Holod S; Finocchietto PV; Camino AM; Aquino JB; Avagnina A; Carreras MC; Poderoso JJ; Gores GJ
    Liver Int; 2015 Mar; 35(3):953-66. PubMed ID: 24750664
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fucoidan and Fucoxanthin Attenuate Hepatic Steatosis and Inflammation of NAFLD through Modulation of Leptin/Adiponectin Axis.
    Shih PH; Shiue SJ; Chen CN; Cheng SW; Lin HY; Wu LW; Wu MS
    Mar Drugs; 2021 Mar; 19(3):. PubMed ID: 33809062
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure.
    Zaitone SA; Barakat BM; Bilasy SE; Fawzy MS; Abdelaziz EZ; Farag NE
    Naunyn Schmiedebergs Arch Pharmacol; 2015 Jun; 388(6):587-600. PubMed ID: 25708949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antiobesity Effects of Salvia plebeia R. Br. Extract in High-Fat Diet-Induced Obese Mice.
    Choi SI; Cho IH; Han SH; Jeon YJ; Choi JG; Kim JS; Lee JH
    J Med Food; 2016 Nov; 19(11):1048-1056. PubMed ID: 27705068
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Voluntary oral feeding of rats not requiring a very high fat diet is a clinically relevant animal model of non-alcoholic fatty liver disease (NAFLD).
    Tipoe GL; Ho CT; Liong EC; Leung TM; Lau TY; Fung ML; Nanji AA
    Histol Histopathol; 2009 Sep; 24(9):1161-9. PubMed ID: 19609863
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Redox imbalance due to the loss of mitochondrial NAD(P)-transhydrogenase markedly aggravates high fat diet-induced fatty liver disease in mice.
    Navarro CDC; Figueira TR; Francisco A; Dal'Bó GA; Ronchi JA; Rovani JC; Escanhoela CAF; Oliveira HCF; Castilho RF; Vercesi AE
    Free Radic Biol Med; 2017 Dec; 113():190-202. PubMed ID: 28964917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Role of Growth Hormone and Insulin-Like Growth Factor-I in the Liver.
    Takahashi Y
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28678199
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral citrulline supplementation protects female mice from the development of non-alcoholic fatty liver disease (NAFLD).
    Sellmann C; Jin CJ; Engstler AJ; De Bandt JP; Bergheim I
    Eur J Nutr; 2017 Dec; 56(8):2519-2527. PubMed ID: 27496089
    [TBL] [Abstract][Full Text] [Related]  

  • 55. fat-1 mice prevent high-fat plus high-sugar diet-induced non-alcoholic fatty liver disease.
    Guo XF; Gao JL; Li JM; Li D
    Food Funct; 2017 Nov; 8(11):4053-4061. PubMed ID: 28972610
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mass-Spectrometry-Based Serum Metabolomics of a C57BL/6J Mouse Model of High-Fat-Diet-Induced Non-alcoholic Fatty Liver Disease Development.
    Lai YS; Chen WC; Kuo TC; Ho CT; Kuo CH; Tseng YJ; Lu KH; Lin SH; Panyod S; Sheen LY
    J Agric Food Chem; 2015 Sep; 63(35):7873-84. PubMed ID: 26262841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice.
    Norris GH; Porter CM; Jiang C; Millar CL; Blesso CN
    J Nutr Biochem; 2017 Feb; 40():36-43. PubMed ID: 27855315
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
    Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
    Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
    [TBL] [Abstract][Full Text] [Related]  

  • 59. (S)YS-51, a novel isoquinoline alkaloid, attenuates obesity-associated non-alcoholic fatty liver disease in mice by suppressing lipogenesis, inflammation and coagulation.
    Park EJ; Kim YM; Kim HJ; Jang SY; Oh MH; Lee DH; Chang KC
    Eur J Pharmacol; 2016 Oct; 788():200-209. PubMed ID: 27343380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A high-fat diet supplemented with medium-chain triglycerides ameliorates hepatic steatosis by reducing ceramide and diacylglycerol accumulation in mice.
    Mourad S; Abdualkader AM; Li X; Jani S; Ceddia RB; Al Batran R
    Exp Physiol; 2024 Mar; 109(3):350-364. PubMed ID: 38192209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.